Thiogenesis Therapeutics held annual and special shareholder meeting

Bitget2026/09/21 08:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Thiogenesis Therapeutics Corp. held its annual and special shareholder meeting on Sept. 8, 2026.
Shareholders backed all items presented, including the appointment of directors to serve until the next annual meeting.
MNP LLP was reappointed as auditor until the next annual meeting or until a successor is appointed.
Disinterested shareholders adopted an amendment to the 2024 Omnibus Equity Incentive Plan; the filing did not confirm implementation steps.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thiogenesis Therapeutics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609210400NEWSFILECNPR____20260921_315046_1) on September 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Thiogenesis Therapeutics held annual and special shareholder meeting

You may also like

Crypto prices